Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA
Status:
Completed
Trial end date:
2020-05-07
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to search for biomarkers associated with the success of
adalimumab treatment in order to generate an algorithm to predict the response to this
treatment at 6 months in spondyloarthritis and to define its metrological properties on this
cohort.
The algorithm will allow to better target patients who will have an important benefit/risk
ratio for adalimumab treatment.